688289 圣湘生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.1174.94827.92940.35798.685
总资产报酬率 ROA (%)0.9424.12723.81735.75585.835
投入资产回报率 ROIC (%)1.0624.84527.46839.55596.520

边际利润分析
销售毛利率 (%)81.09671.53958.83471.66879.636
营业利润率 (%)24.76642.44436.27458.07464.792
息税前利润/营业总收入 (%)19.26135.45035.12358.20665.046
净利润/营业总收入 (%)18.77834.57130.02549.67354.936

收益指标分析
经营活动净收益/利润总额(%)102.4796.158109.76596.77699.853
价值变动净收益/利润总额(%)-15.06976.8813.4223.0970.735
营业外收支净额/利润总额(%)-4.860-4.138-1.031-0.213-0.517

偿债能力分析
流动比率 (X)8.4776.4734.7888.9867.380
速动比率 (X)7.9426.0634.5628.4306.978
资产负债率 (%)13.90912.17518.10610.00012.998
带息债务/全部投入资本 (%)5.7461.0500.4830.9492.025
股东权益/带息债务 (%)1,617.2099,285.78020,361.48510,364.0534,816.617
股东权益/负债合计 (%)600.872699.630451.575898.257669.360
利息保障倍数 (X)-4.421-6.679-44.984227.525110.757

营运能力分析
应收账款周转天数 (天)155.519351.35157.79152.44726.792
存货周转天数 (天)464.059459.63549.13390.94563.355